MARKET

CDXS

CDXS

Codexis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.26
-0.86
-3.89%
Pre Market: 21.30 +0.04 +0.19% 09:28 06/22 EDT
OPEN
22.00
PREV CLOSE
22.12
HIGH
22.02
LOW
21.10
VOLUME
108
TURNOVER
--
52 WEEK HIGH
29.56
52 WEEK LOW
10.48
MARKET CAP
1.37B
P/E (TTM)
-51.0322
1D
5D
1M
3M
1Y
5Y
58 Biggest Movers From Friday
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
Benzinga · 1d ago
Strength Seen in Codexis (CDXS): Can Its 12.6% Jump Turn into More Strength?
Codexis (CDXS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks · 1d ago
Codexis price target raised at H.C. Wainwright citing new purchase order
Fokusiert/iStock via Getty Images A receipt of a new purchase order worth up to $13.9M from an unnamed customer for a proprietary high-performance enzyme product prompted Codexis ([[CDXS]] +12.7%) to raise
Seekingalpha · 3d ago
Codexis Up 10% After Raised Guidance From Purchase Order
marketwatch.com · 3d ago
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 3d ago
Update: Codexis Shares Jump 10% After FY21 Guidance Boost Citing $14 Million Enzyme Order
MT Newswires · 3d ago
Codexis Raises 2021 Revenue Outlook After New Order For Its Enzyme Product
Benzinga · 4d ago
HC Wainwright & Co. Maintains Buy on Codexis, Raises Price Target to $27
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Codexis (NASDAQ:CDXS) with a Buy and raises the price target from $26 to $27.
Benzinga · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CDXS. Analyze the recent business situations of Codexis through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CDXS stock price target is 27.63 with a high estimate of 32.00 and a low estimate of 23.00.
EPS
Institutional Holdings
Institutions: 207
Institutional Holdings: 62.63M
% Owned: 97.11%
Shares Outstanding: 64.49M
TypeInstitutionsShares
Increased
59
5.98M
New
21
870.29K
Decreased
44
4.02M
Sold Out
19
1.82M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.23%
Pharmaceuticals & Medical Research
+0.88%
Key Executives
President/Chief Executive Officer/Director
John Nicols
Chief Financial Officer/Senior Vice President
Ross Taylor
Independent Director
Jennifer Aaker
Senior Vice President
Laurie Heilmann
Independent Director
Stephen Dilly
Independent Director
Byron Dorgan
Independent Director
Esther Martinborough
Independent Director
Alison Moore
Independent Director
David Smith
Director
Patrick Y. Yang
Independent Director
Dennis Wolf
Independent Director
Patrick Yang
No Data
About CDXS
Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.

Webull offers kinds of Codexis, Inc. stock information, including NASDAQ:CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.